SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-047110
Filing Date
2022-12-28
Accepted
2022-12-28 08:44:26
Documents
14
Period of Report
2022-12-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10045977_8k.htm   iXBRL 8-K 29821
2 EXHIBIT 99.1 brhc10045977_ex99-1.htm EX-99.1 24960
6 image00002.jpg GRAPHIC 3325
  Complete submission text file 0001140361-22-047110.txt   203975

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20221228.xsd EX-101.SCH 3872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20221228_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20221228_pre.xml EX-101.PRE 16049
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10045977_8k_htm.xml XML 4239
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 221491693
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences